tiprankstipranks
BioMarin exec Fuchs sells 35,341 common shares
PremiumThe FlyBioMarin exec Fuchs sells 35,341 common shares
1M ago
BioMarin appoints Cristin Hubbard as Chief Commercial Officer
PremiumThe Fly
BioMarin appoints Cristin Hubbard as Chief Commercial Officer
1M ago
New Share Price & Shareholder Rights Risk for Biomarin Pharmaceutical Inc. – What’s the Latest?
PremiumCompany Announcements
New Share Price & Shareholder Rights Risk for Biomarin Pharmaceutical Inc. – What’s the Latest?
2M ago
BioMarin reports Q4 non-GAAP EPS 49c, consensus 23c
PremiumThe FlyBioMarin reports Q4 non-GAAP EPS 49c, consensus 23c
2M ago
BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024
PremiumPress Releases
BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024
2M ago
BioMarin a ‘favorite’ name in Biotech, says Cantor Fitzgerald
PremiumThe Fly
BioMarin a ‘favorite’ name in Biotech, says Cantor Fitzgerald
2M ago
William Blair biotech analysts to hold an analyst/industry conference call
PremiumThe FlyWilliam Blair biotech analysts to hold an analyst/industry conference call
3M ago
William Blair biotech analysts to hold an analyst/industry conference call
PremiumThe Fly
William Blair biotech analysts to hold an analyst/industry conference call
3M ago
William Blair biotech analysts to hold an analyst/industry conference call
PremiumThe Fly
William Blair biotech analysts to hold an analyst/industry conference call
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100